Shareholder Information

Angel pharmaceuticals is a biotech company focus on developing a pipeline of innovative medicines for cancer and autoimmune diseases. 

Angel Pharmaceuticals was launched with strategic collaboration with U.S. biopharmaceutical company Corvus Pharmaceuticals, Inc., with investments from Puissance Capital, Hisun Pharmaceuticals, Tigermed and fund associated with Betta Pharmaceuticals.